COVID-19 vaccine data

COVID-19 vaccinations summary

Second Boosters Administered	1,050,411
Total Doses Administered	13,122,228
First Boosters Administered	2,776,064
Percentage of 12+ who have completed primary course	86.6%
Percentage of eligible 50+ who have received second booster	57.0%
Percentage of eligible 18+ who have received first booster	74.0%

Metrics on this page can use one of two views of the data - An operational view or a person view.

The operational view shows all doses administered in New Zealand. The person view shows the vaccination status of people regardless of how that was recorded or whether it was in New Zealand. Those who have been vaccinated overseas will only appear in the person view, they will not appear in the operational view.

The person view includes all people that are currently alive and in the latest Health Service User (HSU) population. The current HSU in use is the financial year 2022/23 HSU (FY2022/23 HSU). The HSU is an estimate of the population using the health system in New Zealand. A person is included in the HSU if they use health services (including births and deaths) in the reference period, or are enrolled in a primary health organisation (PHO) during the reference period. The reference period for the FY2022/23 HSU is: 1/7/2022 to 30/6/2023.

Total Vaccinations

	Vaccinations last week	Cumulative total
First dose	3,045	4,064,211
Second dose	84	3,987,495
Booster 1	303	2,776,064
Booster 2	2,066	1,050,411
Booster 3+	12,747	812,098
Paediatric First Dose	37	272,503
Paediatric Second Dose	18	159,061
Infant First Dose	0	168
Infant Second Dose	0	130
Infant Third Dose	0	87
Total doses	18,300	13,122,228

This table is an operational view.

Definitions

Cumulative total: All vaccinations that have been administered and entered into the Aotearoa Immunisation Register and including Friday 26 April 2024.
Vaccinations last week: Over the 7 days up to and including Friday 26 April 2024.

Booster breakdowns

Booster counts by ethnicity

Ethnicity	Booster 1 (16-17)	Booster 1 (18+)	Booster 2 (50+)
Māori	548	253,105	65,240
Pacific Peoples	336	147,280	28,554
Asian	1,073	440,715	64,694
European/Other	3,320	1,796,923	691,106
Unknown	11	11,449	3,267
Total	5,288	2,649,472	852,861

This table is a person view.

Booster 2 uptake by age group

Age Group	Eligible	Received	Uptake
18 to 34	162,059	39,689	24.5%
35 to 49	618,689	125,024	20.2%
50 to 64	721,346	292,004	40.5%
65+	773,684	560,857	72.5%

This table is a person view.

Vaccine uptake percentage by age band

A graph showing the ages of people getting the COVID vaccine in New Zealand.

Vaccine uptake percentage by District of residence 12+

A graph showing where the most COVID vaccines are being administered. — *Note, this figure does not include 0-11 year olds

*Note, this figure does not include 0-11 year olds

Vaccinations by week

A graph showing how many COVID vaccinations are happening each week. — * Note, Third Booster + is defined as any booster dose received after a person’s second booster.

* Note, Third Booster + is defined as any booster dose received after a person’s second booster.

This chart shows the count of vaccinations administered in a given week from the Aotearoa Immunisation Register. Note some records are entered in the register at a later date than the immunisation was received. This means that the figures for a given date may move for some time after that date.

Adverse events following immunisations (AEFI)

Like all medicines, the COVID-19 vaccine may cause side effects in some people. These are common, are usually mild, don’t last long and won’t stop people from having the second dose or going about daily life. Serious allergic reactions do occur but are extremely rare.

Suspected AEFI to COVID-19 vaccines are reported to the Centre for Adverse Reactions Monitoring (CARM). Medsafe is closely monitoring the AEFI reported from the use of the COVID-19 vaccine and will report regularly on their findings.

View Medsafe data on COVID-19 vaccine adverse effects following immunisation

On this page